Clinical Trials Directory

Trials / Completed

CompletedNCT04544553

Barriers to Eye Screening for People With Diabetes in India

To Understand the Barriers and Facilitators of Diabetic Retinopathy Screening & Follow-up: An Exploratory Study From India and Thailand

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Lions Club International Foundation · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Brief Summary: Diabetic retinopathy (DR) is a leading cause of visual impairment and has major public health implications globally and especially in countries such as India where the prevalence of diabetes is high. With timely screening and intervention, the disease progression to blindness can be prevented but several barriers exist to the provision of care. The long term aim is to identify the barriers to DR screening and to plan potential interventional strategies. From the qualitative study, the reasons such as lack of awareness or knowledge, distance to travel, lack of reminder system were identified as a reason for poor follow-up. This lead to the development of interventional strategies. This was a randomized, investigator-masked clinical trial that was conducted in a tertiary eye care centre in South India. Consecutive patients with diabetes who were residents in Chennai and its vicinity of approximately 100 km radius and who were undergoing repeated intravitreal injections for DME were recruited into the trial. The aim of the study is to investigate the effect of SMS informational reminders among patients with Diabetic macular edema for the follow-up. They study consists of 2 groups, SMS reminder group receives the reminders 1 week and 2 days prior to the scheduled appointments with the concerned doctor on a particular date and time, whereas other group does not receive any reminders for the appointment schedule. After the follow-up, the patients will be screened for the attendance at the review visit.

Conditions

Interventions

TypeNameDescription
OTHERSMS reminderThe group receives reminder for the follow-up at 1 week and 2 days prior to their scheduled appointments.
OTHERNo SMS reminderThe group did not receives any SMS regarding scheduled appoinments.

Timeline

Start date
2019-01-24
Primary completion
2019-08-14
Completion
2019-08-14
First posted
2020-09-10
Last updated
2020-09-14

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04544553. Inclusion in this directory is not an endorsement.